IgG mAbs targeting sCD146 (SATT Sud Est)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameIgG mAbs targeting sCD146 (SATT Sud Est)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionMelanoma cell adhesion molecule modulatorsImmunoglobulin G agonists
TargetsMelanoma cell adhesion moleculeImmunoglobulin G
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSATT PACA Corse SAS
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSATT PACA Corse SAS
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A